Search

Author/Creator Margolin, Kim A

1. A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in patients (pts) at high risk for recurrence. (4th November 2015)

Authors:
Weber, Jeffrey; Grob, Jean-Jaques; Margolin, Kim A; Ascierto, Paolo A; Sznol, Mario; Ott, Patrick A; Lejeune, Chantal; de Pril, Veerle; Ruisi, Mary M; Hodi, F Stephen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study. Issue 12 (December 2021)

Authors:
Tawbi, Hussein A; Forsyth, Peter A; Hodi, F Stephen; Algazi, Alain P; Hamid, Omid; Lao, Christopher D; Moschos, Stergios J; Atkins, Michael B; Lewis, Karl; Postow, Michael A; Thomas, Reena P; Glaspy, John; Jang, Sekwon; Khushalani, Nikhil I; Pavlick, Anna C; Ernstoff, Marc S; Reardon, David A; Ku...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 12(2021)
Page Start:
1692
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). Issue 9 (29th September 2022)

Authors:
Atkins, Michael B; Abu-Sbeih, Hamzah; Ascierto, Paolo A; Bishop, Michael R; Chen, Daniel S; Dhodapkar, Madhav; Emens, Leisha A; Ernstoff, Marc S; Ferris, Robert L; Greten, Tim F; Gulley, James L; Herbst, Roy S; Humphrey, Rachel W; Larkin, James; Margolin, Kim A; Mazzarella, Luca; Ramalingam, Sure...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 9(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Issue 8 (August 2015)

Authors:
Ribas, Antoni; Puzanov, Igor; Dummer, Reinhard; Schadendorf, Dirk; Hamid, Omid; Robert, Caroline; Hodi, F Stephen; Schachter, Jacob; Pavlick, Anna C; Lewis, Karl D; Cranmer, Lee D; Blank, Christian U; O'Day, Steven J; Ascierto, Paolo A; Salama, April K S; Margolin, Kim A; Loquai, Carmen; Eigentle...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 8(2015:Aug.)
Page Start:
908
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Issue 8 (August 2015)

Authors:
Ribas, Antoni; Puzanov, Igor; Dummer, Reinhard; Schadendorf, Dirk; Hamid, Omid; Robert, Caroline; Hodi, F Stephen; Schachter, Jacob; Pavlick, Anna C; Lewis, Karl D; Cranmer, Lee D; Blank, Christian U; O'Day, Steven J; Ascierto, Paolo A; Salama, April K S; Margolin, Kim A; Loquai, Carmen; Eigentle...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 8(2015:Aug.)
Page Start:
908
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204). Issue 11 (21st April 2021)

Authors:
Tawbi, Hussein A; Forsyth, Peter A; Hodi, F Stephen; Lao, Christopher D; Moschos, Stergios J; Hamid, Omid; Atkins, Michael B; Lewis, Karl; Thomas, Reena P; Glaspy, John A; Jang, Sekwon; Algazi, Alain P; Khushalani, Nikhil I; Postow, Michael A; Pavlick, Anna C; Ernstoff, Marc S; Reardon, David A; ...
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 11(2021)
Page Start:
1961
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗